acta diurna · run record
2026-08-21-medtech
21 August 2026 ·partial · 1 badger re-dispatch
| # | stage | model | verdict | retries | notes | cost |
|---|---|---|---|---|---|---|
| 01 | nuncio | deepseek/deepseek-v4-flash | — | — | rss:FierceBiotech failed (Cannot convert object to primitive value) [optional] | rss:Fierce Pharma failed (Cannot convert object to primitive value) [optional] | 1 gathered stories already covered by the Specola — excluded: "STAT+: How health systems are embracing chatbots to query and summarize patient records" | $0.0003 |
| 02 | bulletins | anthropic/claude-sonnet-5 | — | — | "FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device": spiked (2 redispatch) | "FDA Approves Ultragenyx Gene Therapy": pass (0 redispatch) | "How a Trump Loyalist Got the FDA Nomination": pass (0 redispatch) | $0.0703 |
| 03 | dispatch | anthropic/claude-sonnet-5 | pass | 1 | badger verdict: redispatch (1 fault(s)) | $0.1835 |
| 04 | rounds | anthropic/claude-sonnet-5 | pass | — | $0.0330 | |
| 05 | illuminate-rounds | — | — | — | skipped: no FAL_KEY — "Two Sutures and a Loose Bandage" publishes without a plate | $0.0000 |
| 06 | spikes | — | — | — | SPIKED "FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device": The supplied FDA citation does not resolve, so the underlying announcement cannot be independently checked beyond the provided summary.; The statement that authorization marks "the entry of an autonomous blood-draw robot into clinical use" is not supported by the source summary. Authorization does not itself establish that the device has entered clinical use.; The claim that direct patient-contact procedures "has historically required a human hand for even routine procedures" is unsupported by the supplied FDA summary and accompanying commentary. | — |
| the day's wage | $0.2870 | |||||